Platelets as delivery systems for disease treatments

Adv Drug Deliv Rev. 2010 Sep 30;62(12):1196-203. doi: 10.1016/j.addr.2010.06.007. Epub 2010 Jul 7.

Abstract

Platelets are small, anucleate, discoid shaped blood cells that play a fundamental role in hemostasis. Platelets contain a large number of biologically active molecules within cytoplasmic granules that are critical to normal platelet function. Because platelets circulate in blood through out the body, release biological molecules and mediators on demand and participate in hemostasis as well as many other pathophysiologic processes, targeting expression of proteins of interest to platelets and utilizing platelets as delivery systems for disease treatment would be a logical approach. This paper reviews the genetic therapy for inherited bleeding disorders utilizing platelets as delivery system, with a particular focus on platelet-derived FVIII for hemophilia A treatment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Coagulation
  • Blood Coagulation Disorders / blood
  • Blood Coagulation Disorders / metabolism
  • Blood Coagulation Disorders / therapy*
  • Blood Platelets* / metabolism
  • Cytoplasmic Granules
  • Factor VIII / genetics
  • Factor VIII / metabolism
  • Factor VIII / therapeutic use*
  • Genetic Therapy* / adverse effects
  • Hemophilia A / blood
  • Hemophilia A / genetics
  • Hemophilia A / metabolism
  • Hemophilia A / therapy*
  • Hemophilia B / blood
  • Hemophilia B / genetics
  • Hemophilia B / metabolism
  • Hemophilia B / therapy*
  • Hemostasis
  • Humans
  • Megakaryocytes / physiology
  • Platelet Count

Substances

  • Factor VIII